Director, US Market Access Strategic Evidence

Role: Director of Strategic Evidence focusing on US market access, evidence generation, and AI technologies within the life sciences sector, particularly in oncology. Responsibilities: develop market access strategies by identifying data and evidence priorities; integrate AI and machine learning techniques to analyze healthcare data; design and execute real-world evidence (RWE) projects supporting patient access and therapy value; collaborate across functions including HEOR, Medical Affairs, and market access stakeholders to align evidence strategies; identify data vendors and strategic partners for patient-centric and reimbursement initiatives. Requirements: BS in science with 10+ years, or MS/PhD with 7+ years, experience in market access, data analytics, and evidence generation; strong understanding of AI methodologies like machine learning and predictive analytics; familiarity with US healthcare policy, reimbursement, and regulatory frameworks; experience with claims data, EHR, RWD vendors, and healthcare organizations. Preferred: background in hematology or solid tumor oncology. High-Value: US market access, RWE generation, AI integration, oncology focus, remote role with ~30% travel. Collaboration: cross-functional with account teams, HEOR, Medical Affairs, and external vendors.